BHARATRASNSEBharat Rasayan Limited· Pesticides And AgrochemicalsHighNeutral
Announced Tue, 26 May · 17:26 IST

Bharat Rasayan Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.

Ebitda Margin ExpansionRelated Party TransactionsResults RestatedResults View source PDF

BHARATRAS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.8%1-day move
₹1475.00
prior close
₹1476.90
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.3-1.1-1.2+0.6-0.8-2.9-1.6-1.9-3.6-7.1-2.0-8.6-13.8
Up moveDown movePending
AI summary

Bharat Rasayan Limited reported standalone revenue of ₹1,24,184 Lacs for FY2026, up 5.9% from ₹1,17,300 Lacs in FY2025. Profit after tax grew 14.2% to ₹14,293 Lacs from ₹12,510 Lacs. Operating margin expanded significantly from 14.97% to 17.51%. The Board recommended a final dividend of ₹0.50 per share (10%) subject to shareholder approval. During the year, the company completed a share split (₹10 to ₹5 face value) and 1:1 bonus issue, increasing paid-up capital from ₹4.15 Cr to ₹8.31 Cr. Key Board changes include the resignation of Whole-Time Director Shri Mahabir Prasad Gupta (health reasons) and appointment of his son Shri Vikas Gupta as Additional Director from July 1, 2026. An independent director's tenure also concluded. The company's CARE ratings remain AA- (Long Term) and A1+ (Short Term). Insurance claim for Dahej plant damage is underway. Auditors expressed an unmodified opinion.

Likely market impact

Strong profitability improvement with margin expansion is positive for investors. The related-party appointment of a promoter family member warrants monitoring. The share split and bonus issue adjusts per-share metrics for comparability.